HealthLeaders Media September 23, 2022
The massive infusion puts Verily in a good deal-making position as the health-tech arena grows.
– The infusion will support Verily’s initiatives in data platforms and research and technology that individualize healthcare.
– Analysts have compared Verily’s funding to Amazon’s acquisition of One Medical – both strategies increase their footprints in the healthcare technology market.
– Verily CEO Andy Conrad will become executive chairman of the Verily Board and current president Stephen Gillett will advance to CEO, effective January 2023.
Verily Life Sciences plans to use its newest $1 billion investment round, led by its parent company, Alphabet, to support expanding its focus on precision health, which includes initiatives in real world evidence generation, healthcare data platforms, and...